We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Purple, blue, yellow, green and grey dots on a yellow background representing a microarray.
Industry Insight

The Staying Power of Chromosomal Microarray Analysis: Innovations on the Horizon Will Future Proof Tried and True Technology

Robert Balog describes innovations in microarray testing technology that are contributing to faster turnaround times, automated interpretation and improved coverage.
Close-up of a dog's snout.
Industry Insight

Man’s Best Friend – Solving the Dog Epigenome To Advance Human Oncology

This article discusses how the culture of canine-derived organoid lines can be used to make meaningful observations in the emerging field of comparative oncology, prompting the next revolution in animal and human cancer studies.
Illustration of DNA double helices with a flame pattern in the background.
Industry Insight

Gene Expression Analysis in Cancer Research

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
A, G, C and T letters representing sequencing.
Industry Insight

Expanding the Short-Read Sequencing Space With Novel RNA-Sequencing Library Preparation Workflows

This article discusses the methodology of using common archived biospecimens for RNA sequencing in oncology applications, such as tumor profiling, introducing challenges and innovative solutions.
A picture of medicines.
Industry Insight

Failing Faster To Succeed Sooner in Drug Discovery

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
DNA double helix on a blue background.
Industry Insight

You Have No Moat – The Great AI Democratization Spells New Challenges and Opportunities for SynBio Companies

This article examines the impact of the democratization of computational design and discusses how synthetic biology companies must shift focus if they are to remain competitive.
DNA helix.
Industry Insight

Exploring the Role of Viral Genomics in Pandemic Preparedness

This article discusses why the proactive detection and monitoring of viral threats through genomics studies is vital in preventing future pandemics and empowering healthcare providers in the face of increasing globalization.
A computer-generated image of a DNA double helix.
Industry Insight

Comprehensive Cancer Research Solutions: From Diagnostics to Therapy

At AACR 2023, Technology Networks spoke with Dr. Mark Garner, global cancer segment market manager at Agilent Technologies, to learn how the new SureSelect Cancer CGP assay is empowering the cancer research field.
Computer-generated image of a DNA double helix.
Industry Insight

Advances in DNA Methylation Profiling and Biomarker Discovery

Technology Networks spoke with Anjali Pradhan, senior vice president of product management at Mission Bio, to discuss a new application for DNA methylation analysis, and its potential in uncovering new biological insights and biomarkers that may guide the future of cancer research.
Advertisement